This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of hydrochlorothiazide: A Synthesis of Findings from 14 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of hydrochlorothiazide: A Synthesis of Findings from 14 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Hydrochlorothiazide (HCTZ) is a diuretic widely used to treat hypertension. Various studies have investigated the effects and side effects of HCTZ. 5 examined the dose-dependent effects of HCTZ in seven hypertensive patients receiving the dihydropyridine calcium channel blocker nicardipine. The results showed that blood pressure decreased by approximately 7/3 mmHg regardless of the dose, but potassium, glucose, and uric acid increased in a dose-dependent manner. The hypokalemic and hyperglycemic responses at 50 mg were greater than those usually seen with HCTZ. 4 examined the effects of HCTZ and amiloride on salt excretion (intake) and taste in 73 normotensive adults (aged 18 to 56) who were randomly assigned to receive 50 mg/day of HCTZ (n = 24), 5 mg twice daily of amiloride (n = 24) or placebo (n = 25) for 8 weeks. The results showed that significant increases in sodium excretion (intake) of 31%, 53% and 30% were observed in subjects receiving HCTZ after 2, 4 and 8 weeks of treatment, respectively. 6 investigated the effects of thiazide diuretics on plasma lipoproteins in 16 hypertensive patients in a double-blind, placebo-controlled, crossover study. The results showed that 4 weeks of 50 mg hydrochlorothiazide twice daily, caused significant elevations in total plasma cholesterol, high density lipoprotein (HDL)-cholesterol, low density lipoprotein (LDL)-cholesterol, very low density lipoprotein (VLDL)-cholesterol and triglycerides. 7 studied the antihypertensive and biochemical effects of different doses of hydrochlorothiazide alone or in combination with triamterene in 26 patients with essential hypertension. The results showed that 25 mg of hydrochlorothiazide is as effective in lowering blood pressure as higher doses of the diuretic. 1 compared the effects of ticrynafen (TCNF) with hydrochlorothiazide (HCTZ) on blood pressure (BP), renal function, serum uric acid (UA) and electrolytes, and body fluid spaces in 25 hypertensive subjects in a double-blind, randomized study. The results showed that BP was similarly lowered by TCNF and HCTZ. 14 compared chlorthalidone (CTD) and hydrochlorothiazide (HCTZ) for major cardiovascular events, blood pressure, left ventricular mass, and adverse effects. The results showed that CTD may be more effective in reducing major cardiovascular events than HCTZ. 13 examined the effects of hydrochlorothiazide on oxidative stress and pulse pressure in hypertensive patients with chronic stroke in a randomized, multicenter study. The results showed that hydrochlorothiazide did not provide any additional benefits over non-diuretic antihypertensive drugs in terms of antioxidant effects or reducing pulse pressure. 9 compared the hypocalciuric and potential side-effects of hydrochlorothiazide (HCT) to indapamide (IND; a thiazide-like drug) in patients with idiopathic hypercalciuria. The results showed that IND was at least as effective as HCT in controlling hypercalciuria. 3 compared the antihypertensive and metabolic effects of captopril combined with hydrochlorothiazide (C+HCTZ) versus chlorthalidone (CT) in mild and moderate primary hypertensive patients. The results showed that captopril combined with low diuretic dose normalize the blood pressure in 69% mild to moderate primary hypertensive patients, and acts faster than chlorthalidone in this control. 12 compared the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension. The results showed that LOS + HCTZ did not influence UA metabolism as well as glucose metabolism, likely because of inhibitory action of losartan on URAT1, although TEL + HCTZ were accompanied with impairment of the UA metabolism and glucose metabolism. 10 examined the effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons. The results showed that the urine calcium showed significant decreases from placebo in men at one year, but the effects had waned by 3 years. 8 evaluated the effects of 12.5-mg and 112.5-mg daily doses of hydrochlorothiazide (HCTZ) administered for 1 month to nine postmenopausal black female hypertensives. The results showed that both regimens produced significant reductions in sitting diastolic blood pressure. 11 conducted a meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone. The results suggested that chlorthalidone is more effective in lowering blood pressure at lower doses than hydrochlorothiazide. 2 compared the efficacy of a combination of methyldopa with hydrochlorothiazide with that of its components, methyldopa and hydrochlorothiazide. The results showed that the combination was found to be more efficacious than either of its components.

Benefits and Risks

Benefit Summary

HCTZ is effective in lowering blood pressure and is widely used to treat hypertension. 5 , 7 , 1 , 3 , 12 showed that HCTZ significantly reduces blood pressure. In addition, 10 suggests that HCTZ may have beneficial effects on the skeleton.

Risk Summary

HCTZ may cause side effects such as hypokalemia, hyperglycemia, and hyperuricemia. 5 , 4 , 7 , 1 , 14 , 13 , 9 , 3 , 12 reported these side effects. 6 , 8 also showed that HCTZ may increase blood lipids.

Comparison Across Studies

Commonalities Across Studies

Many studies have shown that HCTZ is effective in lowering blood pressure. It is also consistently reported that HCTZ may cause side effects such as hypokalemia, hyperglycemia, and hyperuricemia.

Differences Across Studies

Studies have reported different degrees of blood pressure lowering effects and side effects of HCTZ. In addition, the effects of HCTZ on blood lipids, its effects on the skeleton, and its combined effects with other drugs vary depending on the study.

Consistency and Inconsistencies of Results

While there is consistency in the research findings regarding the effects and side effects of HCTZ, there are also inconsistencies. For example, the blood pressure lowering effect of HCTZ has been shown to vary depending on the dose, the drug used in combination, and the patient's condition. Furthermore, the side effects of HCTZ have been reported differently depending on the study. These inconsistencies may be explained by differences in research design, subjects, and other factors.

Important Considerations for Real-World Application

HCTZ is an effective drug for treating hypertension, but the risk of side effects should also be considered. Particular caution should be exercised when using HCTZ in elderly patients, patients with kidney disease, and diabetic patients. Regular monitoring of blood pressure, blood potassium levels, and blood sugar levels is important when taking HCTZ. There are various drugs used to treat hypertension besides HCTZ. It is important to consult with your doctor to find the right treatment for you.

Limitations of Current Research

Many studies on HCTZ are small and have a limited number of subjects. In addition, many studies have not been conducted on specific populations (e.g. elderly patients, patients with kidney disease, diabetic patients). Further research is needed to assess the effects and side effects of HCTZ in these populations.

Future Research Directions

Further research on HCTZ should include larger studies and involve diverse populations. More research is also needed on the long-term effects and side effects of HCTZ, as well as its combined effects with other drugs.

Conclusion

HCTZ is effective in lowering blood pressure and is widely used to treat hypertension. However, HCTZ may cause side effects such as hypokalemia, hyperglycemia, and hyperuricemia. It is important to consider the risk of side effects when taking HCTZ and to follow your doctor's instructions. There are various drugs used to treat hypertension besides HCTZ. It is important to consult with your doctor to find the right treatment for you.


Literature analysis of 14 papers
Positive Content
10
Neutral Content
3
Negative Content
1
Article Type
12
2
0
0
14

Language : English


Language : English


Language : Portuguese


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.